Paving the road to personalized medicine: Recommendations on regulatory, intellectual property and reimbursement challenges

Lori Knowles, Westerly Luth, Tania Bubela

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Abstract

Personalized medicine (PM) aims to harness a wave of 'omics' discoveries to facilitate research and discovery of targeted diagnostics and therapies and increase the efficiency of healthcare systems by predicting and treating individual predispositions to diseases or conditions. Despite significant investment, limited progress has been made bringingPMto market.Wedescribe the major perceived regulatory, intellectual property, and reimbursement challenges to the development, translation, adoption, and implementation of PM products into clinical care. We conducted a scoping review to identify (i) primary challenges for the development and implementation of PM identified in the academic literature; (ii) solutions proposed in the academic literature to address these challenges; and (iii) gaps that exist in that literature. We identified regulatory barriers to PM development and recommendations in 344 academic papers. Regulatory uncertainty was a cross-cutting theme that appeared in conjunctionwith other themes including: reimbursement; clinical trial regulation; regulation of co-development; unclear evidentiary requirements; insufficient incentives for research and development; incompatible information systems; and different regulation of different diagnostics. To fully realize the benefits of PM for healthcare systems and patients, regulatory, intellectual property, and reimbursement challenges need to be addressed in lock step with scientific advances.

Original languageEnglish
Pages (from-to)453-506
Number of pages54
JournalJournal of Law and the Biosciences
Volume4
Issue number3
DOIs
Publication statusPublished - 1 Dec 2017
Externally publishedYes

Keywords

  • 'omics'
  • Biomarkers
  • Device regulation
  • Diagnostics
  • Drug regulation
  • Intellectual property
  • Personalized medicine
  • Precision medicine
  • Reimbursement

Fingerprint

Dive into the research topics of 'Paving the road to personalized medicine: Recommendations on regulatory, intellectual property and reimbursement challenges'. Together they form a unique fingerprint.

Cite this